TABLE 3.
Serum analyte (n) | Unadjusted (r, p) | Adjusted for covariates a (r, p) | ||||
---|---|---|---|---|---|---|
Saliva lithium | Serum lithium | Ratio | Saliva lithium | Serum lithium | Ratio | |
Na+ (85) | 0.04, 0.71 | −0.07, 0.51 | 0.05, 0.65 | 0.03, 0.80 | −0.06, 0.60 | 0.01, 0.91 |
K+ (82) | 0.26, 0.02 | 0.30, 0.007 | −0.08, 0.47 | 0.25, 0.03 | 0.32, 0.004 | −0.16, 0.17 |
Cre (85) | 0.03, 0.76 | 0.00, 0.98 | 0.07, 0.57 | 0.10, 0.37 | 0.16, 0.16 | −0.09, 0.44 |
TSH (80) | 0.14, 0.23 | 0.09, 0.45 | 0.07, 0.57 | 0.17, 0.15 | 0.07, 0.56 | 0.11, 0.35 |
WBC (32) | 0.13, 0.48 | 0.12, 0.53 | 0.09, 0.63 | 0.06, 0.78 | −0.05, 0.82 | 0.21, 0.31 |
Abbreviations: Na+, sodium; K+, potassium; Cre, creatinine; TSH, thyroid‐stimulating hormone; WBC, white blood cell count.
Values in bold are statistically significant (p < 0.05).
Covariates: daily lithium dose, dosing schedule, recruitment site, diabetes, smoking.